Morgan Stanley Medpace Holdings, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 237,065 shares of MEDP stock, worth $82.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

237,065

Previous 255,089 7.07%

Holding current value

$82.6 Million

Previous $105 Million 24.75%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$320.58 - $457.29 $5.78 Million - $8.24 Million	-18,024 Reduced 7.07%	237,065 $79.1 Million
Q2 2024 Oct 17, 2024	SELL	$372.0 - $424.34 $47 Million - $53.6 Million	-126,277 Reduced 33.11%	255,089 $105 Million
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $47 Million - $53.6 Million	-126,277 Reduced 33.11%	255,089 $105 Million
Q1 2024 Oct 17, 2024	BUY	$284.87 - $413.31 $36 Million - $52.2 Million	126,277 Added 49.5%	381,366 $154 Million
Q1 2024 Aug 16, 2024	BUY	$284.87 - $413.31 $10.1 Million - $14.6 Million	35,368 Added 10.22%	381,366 $154 Million
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $10.1 Million - $14.6 Million	35,368 Added 10.22%	381,366 $154 Million
Q4 2023 Aug 16, 2024	BUY	$227.52 - $312.68 $20.7 Million - $28.4 Million	90,909 Added 35.64%	345,998 $106 Million
Q4 2023 Feb 13, 2024	BUY	$227.52 - $312.68 $7.99 Million - $11 Million	35,125 Added 11.3%	345,998 $106 Million
Q3 2023 Nov 15, 2023	BUY	$233.98 - $281.67 $5.54 Million - $6.67 Million	23,687 Added 8.25%	310,873 $75.3 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $3.38 Million - $4.33 Million	18,038 Added 6.7%	287,186 $69 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $13.3 Million - $18.3 Million	76,580 Added 39.77%	269,148 $50.6 Million
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $8.81 Million - $13 Million	-57,580 Reduced 23.02%	192,568 $40.9 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $6.01 Million - $7.56 Million	41,406 Added 19.84%	250,148 $39.3 Million
Q2 2022 Oct 27, 2022	BUY	$130.2 - $168.03 $7.45 Million - $9.62 Million	57,229 Added 37.77%	208,742 $31.2 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $7.45 Million - $9.62 Million	57,229 Added 37.77%	208,742 $31.2 Million
Q1 2022 Oct 27, 2022	SELL	$138.87 - $214.31 $7.95 Million - $12.3 Million	-57,229 Reduced 27.42%	151,513 $24.8 Million
Q1 2022 May 13, 2022	BUY	$138.87 - $214.31 $11.4 Million - $17.6 Million	82,247 Added 118.74%	151,513 $24.8 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $4.68 Million - $5.83 Million	-25,585 Reduced 26.97%	69,266 $15.1 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $16.1 Million - $18.8 Million	94,851 New	94,851 $18 Million

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account